<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="abstract"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Breast Cancer Res</journal-id><journal-title-group><journal-title>Breast Cancer Research : BCR</journal-title></journal-title-group><issn pub-type="ppub">1465-5411</issn><issn pub-type="epub">1465-542X</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">3300848</article-id><article-id pub-id-type="publisher-id">bcr150</article-id><article-id pub-id-type="doi">10.1186/bcr150</article-id><article-categories><subj-group subj-group-type="heading"><subject>Meeting Abstract</subject></subj-group></article-categories><title-group><article-title>Mammary-specific targeting of the murine <italic>BRCA2</italic> breast cancer susceptibility gene in mice</article-title></title-group><contrib-group><contrib contrib-type="author" id="A1"><name><surname>Collins</surname><given-names>NK</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A2"><name><surname>McAllister</surname><given-names>KA</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A3"><name><surname>Bennett</surname><given-names>LM</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A4"><name><surname>Wagner</surname><given-names>K-U</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A5"><name><surname>Ward</surname><given-names>T</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A6"><name><surname>Malphurs</surname><given-names>J</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A7"><name><surname>Goulding</surname><given-names>G</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A8"><name><surname>Eddy</surname><given-names>EM</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A9"><name><surname>Davis</surname><given-names>BJ</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A10"><name><surname>Wiseman</surname><given-names>RW</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib></contrib-group><aff id="I1"><label>1</label>National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC 27709 and NIDDK, NIH, Bethesda, MD 20892, USA</aff><pub-date pub-type="ppub"><year>2000</year></pub-date><pub-date pub-type="epub"><day>12</day><month>3</month><year>2000</year></pub-date><volume>2</volume><issue>Suppl 1</issue><supplement><named-content content-type="supplement-title">Second International Symposium on the Molecular Biology of Breast Cancer</named-content></supplement><fpage>P1.16</fpage><lpage>P1.16</lpage><permissions><copyright-statement>Copyright &#x000a9;2000 Current Science Ltd</copyright-statement><copyright-year>2000</copyright-year><copyright-holder>Current Science Ltd</copyright-holder></permissions><conference><conf-date>12-16 March 2000</conf-date><conf-name>Second International Symposium on the Molecular Biology of Breast Cancer</conf-name><conf-loc>Lillehammer, Norway</conf-loc></conference></article-meta></front><body><sec><title>Full text</title><p>Women with inherited mutations in the <italic>BRCA2</italic> gene have a very high lifetime risk of developing breast cancer. Previously, we used gene targeting with embryonic stem cells to generate mice with a mutation that disrupts exons 10 and 11 of the <italic>Brca2</italic> gene. Mice that are homozygous for this mutation exhibit an embryonic lethal phenotype. To overcome this difficulty we have generated mice with <italic>lox</italic>P sites flanking <italic>Brca2</italic> exon 27. Prior studies have shown this C-terminal domain of <italic>Brca2</italic> interacts with Rad51, and cells that lack <italic>Brca2</italic> exon 27 are hypersensitive to gamma-radiation. Therefore, site-specific recombination of <italic>lox</italic>P sites and deletion of exon 27 in this floxed <italic>Brca2</italic> allele by a <italic>Cre</italic> recombinase should disrupt basic functions of <italic>Brca2</italic> in DNA repair. The mammary-gland-specific removal of <italic>Brca2</italic> exon 27 by <italic>Cre</italic>-mediated recombination <italic>in vivo</italic> has been accomplished by crossing the homozygous floxed <italic>Brca2</italic> mice with a mouse mammary tumor virus (MMTV)-<italic>Cre</italic> strain D transgenic mice. Analyses of ROSA26 LacZ <italic>Cre</italic> reporter mice confirm that this MMTV-<italic>Cre</italic> transgene is specifically activated at the onset of puberty in mammary epithelial cells. In parallel studies a germline deletion of exon 27 was created by transiently electroporating embryonic stem cells carrying the floxed <italic>Brca2</italic> allele with a <italic>Cre</italic>-expression plasmid. Surprisingly, mice homozygous for the germline deletion of exon 27 appear to be completely viable at birth, but preliminary studies suggest impaired male fertility. Gross phenotypic abnormalities in mammary gland ductal morphogenesis have not been shown by mammary whole mount preparations in these animals at up to six months of age. These mice are being observed closely for neoplastic development in mammary glands as well as other tissues. Mammary-specific <italic>Brca2</italic><sup>&#x00394;27</sup> mice should be a valuable experimental model mimicking the breast tumor development of women who have inherited a BRCA2 defect and then acquire a secondary somatic BRCA2 mutation.</p></sec></body></article>